Skip to content

Ioxaglic acid

Radiographic Contrast Agent — VARIOUS

Also known as: Hexabrix 160, ioxaglate, ioxaglate meglumine, ioxaglate sodium

FDA approvedATC V08AB03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ioxaglic acid is a drug in the Radiographic Contrast Agent class catalogued in DrugCentral. It was first approved by the FDA in 1985. Its mechanism of action is classified as X-Ray Contrast Activity.

  • Drug class: Radiographic Contrast Agent.
  • Mechanism of action: X-Ray Contrast Activity.
  • ATC code: V08AB03 (Watersoluble, nephrotropic, low osmolar X-ray contrast media).
  • Molecular formula: C24H21I6N5O8; molecular weight 1268.89 g/mol.

Mechanism & targets

Mechanism of action (MoA)X-Ray Contrast Activity
Established pharmacologic classRadiographic Contrast Agent

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1985-07-26FDA——

ATC classification

ATC codeTherapeutic hierarchy
V08AB03VARIOUS › CONTRAST MEDIA › X-RAY CONTRAST MEDIA, IODINATED › Watersoluble, nephrotropic, low osmolar X-ray contrast media

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Ioxaglic acid is on its molecule page.

Molecular formulaC24H21I6N5O8
Molecular weight1268.89 g/mol
CAS number59017-64-0
InChIKeyTYYBFXNZMFNZJT-UHFFFAOYSA-N
PubChem CID3742
CNC(=O)C1=C(I)C(C(=O)NCC(=O)NC2=C(I)C(C(=O)NCCO)=C(I)C(C(O)=O)=C2I)=C(I)C(N(C)C(C)=O)=C1I

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Ioxaglic acid work?

Ioxaglic acid is classified as X-Ray Contrast Activity.

When was Ioxaglic acid first approved?

Ioxaglic acid was first approved by the FDA in 1985.

What drug class does Ioxaglic acid belong to?

Ioxaglic acid is in the Radiographic Contrast Agent class.

What is the chemical formula of Ioxaglic acid?

Ioxaglic acid has the molecular formula C24H21I6N5O8 and a molecular weight of 1268.89 g/mol.

Browse: all drugs starting with I · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1985-07-26
AgencyFDA
Targets0
Indications0
FormulaC24H21I6N5O8
DrugCentral ID1472
Interactive profile